ArticleHaematologica2025

Targeting the membrane-proximal domain of CD33 to maximize the efficacy of natural killer cell-based immunotherapies.

Sheryl Y T Lim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.